Disclosures for "Siponimod Stabilizes Physical Disability Scores in People Living With Secondary Progressive Multiple Sclerosis After 2 Years of Treatment: Analysis From the Novartis Global Managed Access Program")
-
Dr. Mavrikis Cox has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Dr. Mavrikis Cox has stock in Novartis Pharmaceuticals.
-
Virginia DeLasHeras has nothing to disclose.
-
Dr. Ryan has received personal compensation for serving as an employee of Novartis.
-
Mrs. Istrate has nothing to disclose.
-
Soudeh Ansari has received personal compensation for serving as an employee of Novartis.
-
Sophie Arnould has nothing to disclose.
-
Dr. Piani Meier has received personal compensation for serving as an employee of Novartis. Dr. Piani Meier has received personal compensation for serving as an employee of Merck Group.